Elon Musk is on weight loss drug bandwagon

Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
Age and the new weight-loss drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Obesity rates are down. Is that because of weight-loss drugs?
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.
Elon Musk shows support for weight loss drugs despite RFK Jr.'s criticism
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
Elon Musk is on the weight loss drug bandwagon
Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency (DOGE), is doubling down on his support for expanding access to affordable GLP-1 weight-loss medications like Ozempic.
Elon Musk reveals support for drugs like Ozempic — in direct contrast to Trump’s HHS pick RFK Jr.
Elon Musk, one of President-elect Donald Trump’s closest confidants, revealed Wednesday his support for weight-loss drugs like Ozempic being made cheaper for the general public — in contrast with comments Health and Human Services Secretary-designate Robert F.
Weight loss costs: Iowans struggle with insurance and access to ozempic, other GLP-1 drugs
Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound ...
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
In new trial, Zepbound bests Wegovy for weight loss
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
Lifestyle News Live Today December 12, 2024: Woman lost impressive amount of arm and back fat without any stretch marks or loose skin with this simple home workout
Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...
Science Daily3d
Diet and Weight Loss News
Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
Weight loss may bring big healthcare savings to Americans
Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...